The effect of recurrent seizures on cognitive, behavioral, and quality-of-life outcomes after 12months of monotherapy in adults with newly diagnosed or previously untreated partial epilepsy

Epilepsy and Behavior

Volumn 53, Issue , 2015, Pages 202-208

  Lee, Sang Ahm ^a   Kim, Min Ju ^a   Lee, Hyang Woon ^b   Heo, Kyoung ^c   Shin, Dong Jin ^d   Song, Hong Ki ^e   Kim, Ok Joon ^f   Kim, Seon Ok ^g   Lee, Byung In ^c  

^a University of Ulsan College of Medicine   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c Yonsei University   (South Korea)

^d Gachon University College of Medicine   (South Korea)

^e Hallym University   (South Korea)

^f CHA University   (South Korea)

^g University of Ulsan   (South Korea)

Author keywords

Behavior; Cognition; Epilepsy; Newly diagnosed; Quality of life

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; ANTICONVULSIVE AGENT; TRIAZINE DERIVATIVE;

ADOLESCENT; ADULT; ANTICONVULSANT ACTIVITY; ARTICLE; BEHAVIOR; COGNITION; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; FOCAL EPILEPSY; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; ONSET AGE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; QUALITY OF LIFE; QUALITY OF LIFE IN EPILEPSY 31; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SOCIAL STATUS; STROOP TEST; SYMPTOM CHECKLIST 90; TRAIL MAKING TEST; TREATMENT DURATION; TREATMENT RESPONSE; WECHSLER ADULT INTELLIGENCE SCALE; CLINICAL TRIAL; DRUG EFFECTS; EPILEPSIES, PARTIAL; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; PSYCHOLOGY; SEIZURES; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; COGNITION; EPILEPSIES, PARTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECURRENCE; SEIZURES; TREATMENT OUTCOME; TRIAZINES;

EID: 84947208324     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.10.020     Document Type: Article

References (39)

1. Hermann B.P., Seidenberg M., Dow C., et al. Cognitive prognosis in chronic temporal lobe epilepsy. Ann Neurol 2006, 60:80-87.
2. Kwon O.Y., Park S.P. Depression and anxiety in people with epilepsy. J Clin Neurol 2014, 10:175-188.
3. Taylor R.S., Sander J.W., Taylor R.J., Baker G.A. Predictors of health-related quality of life and costs in adults with epilepsy: A systematic review. Epilepsia 2011, 52:2168-2180.
4. Suurmeijer T.P., Reuvekang M.F., Aldenkamp B.P. Social functioning, psychological functioning, and quality of life in epilepsy. Epilepsia 2001, 42:1160-1168.
5. Johnson E.K., Jones J.E., Seidenberg M., Hermann B.P. The relative impact of anxiety, depression, and clinical seizure features on health related quality of life in epilepsy. Epilepsia 2004, 45:544-550.
6. Helmstaedter C., Kurthen M., Lux S., et al. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol 2003, 54:425-432.
7. Spencer S.S., Berg A.T., Vickrey B.G., et al. Health-related quality of life over time since respective epilepsy surgery. Ann Neurol 2007, 62(442):327-334.
8. Taylor J., Baker G.A. Newly diagnosed epilepsy: cognitive outcome at 5years. Epilepsy Behav 2010, 18:397-403.
9. Baker G.A., Taylor J., Aldenkamp A.P. Newly diagnosed epilepsy: cognitive outcome after 12months. Epilepsia 2011, 52:1084-1091. on behalf of the SANAD group.
10. Lee S.A., Lee H.W., Heo K., et al. Cognitive and behavioral effects of lamotrigine and carbamazepine monotherapy in patients with newly diagnosed or untreated partial epilepsy. Seizure 2011, 20:49-54.
11. Lim Y.R., Lee W.K., Lee W.H., Park J.W. The study on the accuracy and validity of Korean Wechsler Intelligence Scale short forms: a comparison of the WAR07 subtest vs Doppelt subtest. Korean J Clin Psychol 2000, 19:563-574.
12. Kim J.K., Kang Y.W. Korean-California Verbal Learning Test (K-CVLT): a normative study. Korean J Clin Psychol 1997, 16:379-395.
13. Meyers J.E., Meyers K.R. Rey Complex Figure Test and Recognition Trial 1995.
14. Wechsler D. WAIS-III: Wechsler Adult Intelligence Scale 1997, Psychological Corporation, San Antonio, TX. 3rd ed.
15. Strauss E., Sherman E.M.S., Spreen O. A compendium of neuropsychological tests: administration, norms and commentary 2006, Oxford University Press, New York, NY. 3rd ed.
16. Lee J.H., Kang Y.W., Na D.L. Efficiencies of Stroop Interference Indexes in healthy older adults and dementia patients. Korean J Clin Psychol 2000, 19:807-818.
17. Lee J.H., Kang Y.W., Jin J.H., Na D.L., Park J.S. A normative study of the Korean version of Controlled Oral Word Association Test (COWAT) in the elderly. Korean J Clin Psychol 2000, 19:385-392.
18. Kim K.I., Won H.T., Lee J.H., Kim K.Y. Standardization study of symptom check list-90 in Korea I: characteristics of normal responses. J Korean Neuropsychiatr Assoc 1978, 17:449-458.
19. Yoo H.J., Lee S.A., Heo K., et al. The reliability and validity of Korean QOLIE-31 in patients with epilepsy. J Korean Epileptic Soc 2002, 6:45-52.
20. Adams K.M., Brown G.G., Grant I. Analysis of covariance as a remedy for demographic mismatch of research subject groups: some sobering simulations. J Clin Exp Neuropsychol 1985, 7:445-462.
21. Delis D.C., Kramer J.H., Kaplan E., Ober B.A. California Verbal Learning Test 2000, Pearson Education, Inc., San Antonio. 2nd ed.
22. Dodrill C.B. Progressive cognitive decline in adolescents and adults with epilepsy. Prog Brain Res 2002, 135:399-407.
23. Aikia M., Kalviainen R., Mervaala E., et al. Predictors of seizure outcome in newly diagnosed partial epilepsy: memory performance as a prognostic factor. Epilepsy Res 1999, 37:159-167.
24. Holmes M.D., Dodrill C.B., Wilkus R.J., et al. Is partial epilepsy progressive? Ten-year follow-up of EEG and neuropsychological changes in adults with partial seizures. Epilepsia 1998, 39:1189-1193.
25. Selwa L.M., Berent S., Giordani B., et al. Serial cognitive testing in temporal lobe epilepsy: longitudinal changes with medical and surgical therapies. Epilepsia 1994, 35:743-749.
26. Pacagnella D., Lopes T.M., Morita M.E., et al. Memory impairment is not necessarily related to seizure frequency in mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 2014, 55:1197-1204.
27. Salmenpera T.M., Duncan J.S. Imaging in epilepsy. J Neurol Neurosurg Psychiatry 2005, 76(Suppl. 3):iii2-iii10.
28. Alessio A., Kobayashi E., Damasceno B.P., et al. Evidence of memory impairment in asymptomatic individuals with hippocampal atrophy. Epilepsy Behav 2004, 5:981-987.
29. Gillham R., Kane K., Bryant-Comstock L., Brodie M.J. A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure. Seizure 2000, 9:375-379.
30. Kane K., Bryant-Comstock L., Gillham R.A. Relationship between side effect and life satisfaction (SEALS) score, seizure occurrence and side effects to treatment in newly diagnosed patients with epilepsy. Epilepsia 1997, 38(Suppl. 3):163.
31. Modi A.C., Ingerski L.M., Rausch J.R., Glauser T.A. Treatment factors affecting longitudinal quality of life in new onset pediatric epilepsy. J Pediatr Psychol 2011, 36:466-475.
32. Speechley K.N., Ferro M.A., Camfield C.S., et al. Quality of life in children with new-onset epilepsy. A 2-year prospective cohort study. Neurology 2012, 79:1548-1555.
33. Leidy N.K., Elixhauser A., Vickrey B., Means E., Willian M.K. Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology 1999, 53:162-166.
34. Kang S.H., Yum M.S., Kim E.H., Kim H.W., Ko T.S. Cognitive function in childhood epilepsy: importance of attention deficit hyperactivity disorder. J Clin Neurol 2015, 11:20-25.
35. Velissaris S.L., Wilson S.J., Saling M.M., Newton M.R., Berkovic S.F. The psychological impact of a newly-diagnosed seizure: losing and restoring perceived control. Epilepsy Behav 2007, 10:223-233.
36. Velissaris S.L., Saling M.M., Newton M.R., Berkovic S.F., Wilson S.J. Psychological trajectories in the year after a newly diagnosed seizure. Epilepsia 2012, 53:1774-1781.
37. Taylor J., Kolamunnage-Dona R., Marson A.G., Smith P.E., Aldenkamp A.P., Baker G.A. Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment?. Epilepsia 2010, 51:48-56.
38. Witt J.A., Helmstaedter C. Should cognition be screened in new-onset epilepsies? A study in 247 untreated patients. J Neurol 2012, 259:1727-1731.
39. Potter J.L., Schefft B.K., Beebe D.W., Howe S.R., Yeh H.S., Privitera M.D. Presurgical neuropsychological testing predicts cognitive and seizure outcomes after anterior temporal lobectomy. Epilepsy Behav 2009, 16:246-253.